NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $103,590 | -14.0% | 2,341 | -5.4% | 0.00% | – |
Q2 2023 | $120,433 | -15.2% | 2,475 | -3.2% | 0.00% | – |
Q1 2023 | $142,020 | +28.9% | 2,558 | -6.7% | 0.00% | – |
Q4 2022 | $110,186 | -3.3% | 2,743 | +5.7% | 0.00% | – |
Q3 2022 | $114,000 | +37.3% | 2,595 | +11.2% | 0.00% | – |
Q2 2022 | $83,000 | 0.0% | 2,334 | +13.9% | 0.00% | – |
Q1 2022 | $83,000 | +36.1% | 2,049 | +215.2% | 0.00% | – |
Q4 2021 | $61,000 | -28.2% | 650 | -14.4% | 0.00% | – |
Q3 2021 | $85,000 | +4.9% | 759 | +7.5% | 0.00% | – |
Q2 2021 | $81,000 | +285.7% | 706 | +239.4% | 0.00% | – |
Q1 2021 | $21,000 | +75.0% | 208 | +80.9% | 0.00% | – |
Q4 2020 | $12,000 | +140.0% | 115 | +55.4% | 0.00% | – |
Q3 2020 | $5,000 | +66.7% | 74 | +10.4% | 0.00% | – |
Q2 2020 | $3,000 | – | 67 | +2133.3% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 3 | -99.9% | 0.00% | – |
Q4 2019 | $76,000 | -96.9% | 2,257 | -96.9% | 0.00% | -100.0% |
Q3 2019 | $2,425,000 | -16.5% | 73,909 | -29.8% | 0.00% | -33.3% |
Q2 2019 | $2,904,000 | – | 105,301 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,100,560 | $314,831,000 | 18.93% |
Blue Water Life Science Advisors, LP | 328,836 | $33,390,000 | 16.31% |
Foresite Capital Management III, LLC | 127,305 | $12,927,000 | 11.35% |
HWG Holdings LP | 148,794 | $15,109,000 | 7.53% |
Eagle Health Investments LP | 168,394 | $17,099,000 | 6.71% |
Lagoda Investment Management, L.P. | 103,325 | $10,492,000 | 5.24% |
Ally Bridge Group (NY) LLC | 218,000 | $22,136,000 | 4.24% |
PERKINS CAPITAL MANAGEMENT INC | 63,950 | $6,493,000 | 3.76% |
BRIDGER MANAGEMENT, LLC | 388,620 | $39,460,000 | 3.68% |
Hudson Executive Capital LP | 527,086 | $53,520,000 | 3.32% |